CRISIL downgrades Panacea Biotec fundamental grade to 2/5 Myiris.com Its existing formulations such as Tacrolimus and Cyclosporine continue to gain traction in the overseas market. It has also launched new formulations in different therapeutic segments such as nephrology and immunosuppressant. In addition, the company ... |
